Abstract
The most common cancer for women in the United Kingdom is breast cancer and it is well known that genomic modifications are responsible for breast carcinogenesis. Major developments in genomics and proteomics have uncovered biomarkers which have a crucial role in this process. To move towards individualized and improved breast cancer care, there is a need for tumor markers that are associated with disease diagnosis, prognosis, treatment and monitoring. General opinion is that biomarkers can bring more accurate and sensitive tools to the clinical settings than conventional approved histopathological parameters. However, clinical applications of breast tumor markers remain quite low in numbers because the data regarding these novel markers for breast cancer is limited and do not allow well-grounded conclusions. This review presents a non exhaustive selection of biomarkers published, some validated, and their uses in breast cancer management.
Keywords: Breast cancer, tumor markers, diagnosis, prognosis, therapy, NPI
Current Cancer Therapy Reviews
Title: Emerging Breast Cancer Biomarkers
Volume: 4 Issue: 2
Author(s): Stephanie A. Laversin, Amanda K. Miles, Graham R. Ball and Robert C. Rees
Affiliation:
Keywords: Breast cancer, tumor markers, diagnosis, prognosis, therapy, NPI
Abstract: The most common cancer for women in the United Kingdom is breast cancer and it is well known that genomic modifications are responsible for breast carcinogenesis. Major developments in genomics and proteomics have uncovered biomarkers which have a crucial role in this process. To move towards individualized and improved breast cancer care, there is a need for tumor markers that are associated with disease diagnosis, prognosis, treatment and monitoring. General opinion is that biomarkers can bring more accurate and sensitive tools to the clinical settings than conventional approved histopathological parameters. However, clinical applications of breast tumor markers remain quite low in numbers because the data regarding these novel markers for breast cancer is limited and do not allow well-grounded conclusions. This review presents a non exhaustive selection of biomarkers published, some validated, and their uses in breast cancer management.
Export Options
About this article
Cite this article as:
Laversin A. Stephanie, Miles K. Amanda, Ball R. Graham and Rees C. Robert, Emerging Breast Cancer Biomarkers, Current Cancer Therapy Reviews 2008; 4 (2) . https://dx.doi.org/10.2174/157339408784310179
DOI https://dx.doi.org/10.2174/157339408784310179 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Macrolides as Immunomodulatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Meet Our Editorial Board Member
Current Clinical Pharmacology Liver and Pancreatic Disease in Cystic Fibrosis: Clinics and Drug Therapy
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Combined Therapies of Bone Disease with Bisphosphonates
Current Pharmaceutical Design Bioproducts from Seaweeds: A Review with Special Focus on the Iberian Peninsula
Current Organic Chemistry Shear-Wave and Strain Elastography: A Comparative Review on Principles, Basic Techniques and Applications.
Current Medical Imaging Targeted Drug Delivery for Breast Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Mutations in MicroRNA Genes and Their Binding Sites are Infrequently Associated with Human Colorectal Cancer in the Kashmiri Population
MicroRNA The Functional Role of Long Non-coding RNA UCA1 in Human Multiple Cancers: a Review Study
Current Molecular Medicine Dormant Circulating Tumor Cells in Prostate Cancer: Therapeutic, Clinical and Biological Implications
Current Drug Targets A Sample Selection Strategy to Boost the Statistical Power of Signature Detection in Cancer Expression Profile Studies
Anti-Cancer Agents in Medicinal Chemistry Routine Collection of Patient-Reported Outcomes in an HIV Clinic Setting:The First 100 Patients
Current HIV Research Protective and Therapeutic Effects of Ghrelin in the Gut
Current Medicinal Chemistry Indoleamine 2,3-dioxygenase as a Modifier of Pathogenic Inflammation in Cancer and other Inflammation-Associated Diseases
Current Medicinal Chemistry Multicomponent Reactions for the Synthesis of Bioactive Compounds: A Review
Current Organic Synthesis Alkyl Caffeates as Anti-Helicobacter Pylori and Scavenger of Oxidants Produced by Neutrophils
Medicinal Chemistry Mast Cells as Target in Cancer Therapy
Current Pharmaceutical Design Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery Structure-Function Relationships of Plasminogen Activator Inhibitor-1 and Its Potential as a Therapeutic Agent
Current Drug Targets Neuroprotection by Resveratrol in Diabetic Neuropathy: Concepts & Mechanisms
Current Medicinal Chemistry